Ritonavir/saquinavir safety concerns curtail antiretroviral therapy options for tuberculosis–HIV-co-infected patients in resource-constrained settings.

Authors
Publication date
1 January 2005
Publisher
Lippincott Williams & Wilkins.

Abstract

CorrespondenceNo abstract available

    Similar works

    Full text

    thumbnail-image

    Available Versions

    ResearchSpace@UKZN

    redirect
    oaioai:researchspace.ukzn.ac.za:1...
    Last time updated on 23/11/2020